US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aligos Therapeutics, Inc.

7.32

+0.830012.79%

Post-market: 7.320.00000.00%16:10 EST

Volume:78.02K

Turnover:563.16K

Market Cap:45.04M

PE:-0.54

High:7.47

Open:6.70

Low:6.70

Close:6.49

52wk High:29.54

52wk Low:3.76

Shares:6.15M

Float Shares:3.00M

Volume Ratio:1.28

T/O Rate:2.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-13.5400

EPS(LYR):-20.9448

ROE:-141.82%

ROA:-54.70%

PB:0.63

PE(LYR):-0.35

Loading ...

Overview Company News Filings

Aligos Therapeutics Appoints New Principal Accounting Officer

Aligos Therapeutics ernennt Nikhil Aneja zum Principal Accounting Officer

Aligos Therapeutics announces inducement grants under Nasdaq listing rule

Aligos Therapeutics Grants Stock Options to New Employees Under 2024 Inducement Plan

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies

BUZZ-Aligos rises as mid‑stage trial for hepatitis B drug advances

Aligos Therapeutics provides update for Phase 2 study of pevifoscorvir sodium

Aligos Therapeutics Chief Medical Officer Hardean Achneck Resigns

Aligos Therapeutics Inc: Study Remains on Track to Complete Enrollment, With Topline Data Expected in 2027

THOMSON REUTERS

Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

Aligos Therapeutics management to meet virtually with Piper Sandler

Aligos’ New Phase 1 Hepatitis B Study Signals Steady Progress in High-Need Market

Aligos Therapeutics appoints James Hassard as EVP, CCO

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer

Aligos Therapeutics Initiated at Buy by UBS

UBS Initiates Aligos Therapeutics at Buy With $20 Price Target

MT Newswires Live

Aligos Therapeutics Grants Stock Options to New Hires Under 2024 Inducement Plan

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Reports Positive Phase 1 Results for Pevifoscorvir Sodium in Chronic Hepatitis B

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALGS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALGS\",,,,,undefined,":{"symbol":"ALGS","market":"US","secType":"STK","nameCN":"Aligos Therapeutics, Inc.","latestPrice":7.32,"timestamp":1770411600000,"preClose":6.49,"halted":0,"volume":78020,"hourTrading":{"tag":"盘后","latestPrice":7.32,"preClose":7.32,"latestTime":"16:10 EST","volume":353,"amount":2583.96,"timestamp":1770412204688,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.12788906009244994,"floatShares":3001986,"shares":6153600,"eps":-13.54,"marketStatus":"Post-Mkt","change":0.83,"latestTime":"02-06 18:14:13 EST","open":6.7,"high":7.465,"low":6.7,"amount":563162.5734,"amplitude":0.117874,"askPrice":7.52,"askSize":50,"bidPrice":6.55,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-13.54,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770426000000},"marketStatusCode":4,"adr":0,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":6.49,"postHourTrading":{"tag":"盘后","latestPrice":7.32,"preClose":7.32,"latestTime":"16:10 EST","volume":353,"amount":2583.96,"timestamp":1770412204688,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.281394,"impliedVol":0.1576,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALGS\",,,,,undefined,":{"symbol":"ALGS","floatShares":3001986,"roa":"-54.70%","roe":"-141.82%","lyrEps":-20.944792,"volumeRatio":1.281394,"shares":6153600,"dividePrice":0,"high":7.465,"amplitude":0.117874,"preClose":6.49,"low":6.7,"week52Low":3.76,"pbRate":"0.63","psRate":"17.02","week52High":29.54,"institutionHeld":0,"latestPrice":7.32,"committee":0.333333,"eps":-13.54,"divideRate":0,"volume":78020,"delay":0,"ttmEps":-13.54,"open":6.7,"prevYearClose":9.32,"prevWeekClose":8.07,"prevMonthClose":8.07,"prevQuarterClose":9.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALGS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"ALGS","fiscalQuarterEnding":"2025/09","expectedEps":-2.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-3.04},{"market":"US","date":"2025-08-06","symbol":"ALGS","fiscalQuarterEnding":"2025/06","expectedEps":-2.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.53},{"market":"US","date":"2025-05-06","symbol":"ALGS","fiscalQuarterEnding":"2025/03","expectedEps":-2.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-2.11},{"market":"US","date":"2025-03-10","symbol":"ALGS","fiscalQuarterEnding":"2024/12","expectedEps":-1.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"pre","actualEps":-3.41},{"market":"US","date":"2024-11-06","symbol":"ALGS","fiscalQuarterEnding":"2024/09","expectedEps":-2.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-3.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALGS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALGS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1767762000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALGS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALGS","date":"2026-02-05","current":-0.54062,"percent":0.677393,"low":-12.619664,"twenty":-1.646539,"median":-0.643665,"eighty":-0.421947,"high":-0.18593,"avg":-1.809137,"sd":2.637403,"marketCap":43505824},"quantilePoints":[{"date":"2021-02-12","current":-10.418656,"twenty":-11.703747,"median":-9.828142,"eighty":-7.57395,"marketCap":961714869},{"date":"2021-02-19","current":-12.305824,"twenty":-12.21002,"median":-9.889054,"eighty":-7.588088,"marketCap":1135913718},{"date":"2021-02-26","current":-11.8681,"twenty":-12.076226,"median":-10.048107,"eighty":-7.613335,"marketCap":1095508733},{"date":"2021-03-05","current":-9.254145,"twenty":-12.056404,"median":-10.012455,"eighty":-7.621414,"marketCap":854222363},{"date":"2021-03-12","current":-10.794438,"twenty":-11.997765,"median":-9.976802,"eighty":-7.632522,"marketCap":996402167},{"date":"2021-03-19","current":-9.972673,"twenty":-11.895354,"median":-10.073353,"eighty":-7.67728,"marketCap":920547526},{"date":"2021-03-26","current":-6.711954,"twenty":-11.844975,"median":-9.972673,"eighty":-7.613335,"marketCap":728535654},{"date":"2021-04-01","current":-7.731047,"twenty":-11.774774,"median":-9.947121,"eighty":-7.581019,"marketCap":839151016},{"date":"2021-04-09","current":-7.544799,"twenty":-11.630242,"median":-9.829565,"eighty":-7.57395,"marketCap":818935105},{"date":"2021-04-16","current":-7.593996,"twenty":-11.613725,"median":-9.654262,"eighty":-7.57395,"marketCap":824275157},{"date":"2021-04-23","current":-8.599033,"twenty":-11.555086,"median":-9.598955,"eighty":-7.57395,"marketCap":933364789},{"date":"2021-04-30","current":-9.039376,"twenty":-11.424595,"median":-9.547337,"eighty":-7.57395,"marketCap":981160978},{"date":"2021-05-07","current":-9.534925,"twenty":-11.391559,"median":-9.530807,"eighty":-7.57395,"marketCap":1034949352},{"date":"2021-05-14","current":-6.958349,"twenty":-11.254461,"median":-9.517352,"eighty":-7.57395,"marketCap":808476691},{"date":"2021-05-21","current":-8.830109,"twenty":-11.122318,"median":-9.406935,"eighty":-7.570308,"marketCap":1025952724},{"date":"2021-05-28","current":-9.155204,"twenty":-11.080197,"median":-9.45236,"eighty":-7.57395,"marketCap":1063724877},{"date":"2021-06-04","current":-9.608367,"twenty":-11.017429,"median":-9.361511,"eighty":-7.57395,"marketCap":1116376969},{"date":"2021-06-11","current":-11.033532,"twenty":-11.017429,"median":-9.503395,"eighty":-7.57395,"marketCap":1281963984},{"date":"2021-06-18","current":-8.50173,"twenty":-10.972005,"median":-9.45236,"eighty":-7.57395,"marketCap":987799034},{"date":"2021-06-25","current":-8.797271,"twenty":-10.893545,"median":-9.303189,"eighty":-7.583454,"marketCap":1022137355},{"date":"2021-07-02","current":-6.489925,"twenty":-10.835732,"median":-9.191326,"eighty":-7.57395,"marketCap":754051386},{"date":"2021-07-09","current":-5.889277,"twenty":-10.802697,"median":-9.148637,"eighty":-7.551132,"marketCap":684263335},{"date":"2021-07-16","current":-5.676853,"twenty":-10.751492,"median":-9.129058,"eighty":-7.499119,"marketCap":659582195},{"date":"2021-07-23","current":-6.061414,"twenty":-10.734148,"median":-9.078641,"eighty":-7.470944,"marketCap":704263569},{"date":"2021-07-30","current":-5.336242,"twenty":-10.725889,"median":-9.005987,"eighty":-7.422198,"marketCap":620007263},{"date":"2021-08-06","current":-5.38697,"twenty":-10.677987,"median":-8.894881,"eighty":-7.32982,"marketCap":674497177},{"date":"2021-08-13","current":-5.349537,"twenty":-10.623478,"median":-8.846528,"eighty":-7.125805,"marketCap":669810210},{"date":"2021-08-20","current":-5.158968,"twenty":-10.602831,"median":-8.797271,"eighty":-6.955722,"marketCap":645949286},{"date":"2021-08-27","current":-5.631987,"twenty":-10.566539,"median":-8.675994,"eighty":-6.708364,"marketCap":705175507},{"date":"2021-09-03","current":-5.805541,"twenty":-10.479578,"median":-8.599033,"eighty":-6.486995,"marketCap":726905991},{"date":"2021-09-10","current":-5.179387,"twenty":-10.445085,"median":-8.50173,"eighty":-6.046764,"marketCap":648505814},{"date":"2021-09-17","current":-5.519688,"twenty":-10.429688,"median":-8.295579,"eighty":-5.812358,"marketCap":691114606},{"date":"2021-09-24","current":-5.349537,"twenty":-10.421606,"median":-8.23246,"eighty":-5.756245,"marketCap":669810210},{"date":"2021-10-01","current":-5.308701,"twenty":-10.361669,"median":-8.174056,"eighty":-5.6937,"marketCap":664697155},{"date":"2021-10-08","current":-4.713174,"twenty":-10.301379,"median":-8.099077,"eighty":-5.66404,"marketCap":590131769},{"date":"2021-10-15","current":-5.414195,"twenty":-10.263829,"median":-7.941893,"eighty":-5.569808,"marketCap":677905880},{"date":"2021-10-22","current":-5.349537,"twenty":-10.23918,"median":-7.83647,"eighty":-5.52173,"marketCap":669810210},{"date":"2021-10-29","current":-5.421001,"twenty":-10.23283,"median":-7.779138,"eighty":-5.512546,"marketCap":678758056},{"date":"2021-11-05","current":-5.739508,"twenty":-10.228772,"median":-7.726241,"eighty":-5.507458,"marketCap":717656656},{"date":"2021-11-12","current":-5.865614,"twenty":-10.155794,"median":-7.627985,"eighty":-5.509039,"marketCap":733424647},{"date":"2021-11-19","current":-5.453215,"twenty":-10.105768,"median":-7.609295,"eighty":-5.509039,"marketCap":681859056},{"date":"2021-11-26","current":-5.545238,"twenty":-10.101629,"median":-7.583454,"eighty":-5.506997,"marketCap":693365427},{"date":"2021-12-03","current":-4.44437,"twenty":-10.078403,"median":-7.57395,"eighty":-5.480349,"marketCap":555715130},{"date":"2021-12-10","current":-4.055828,"twenty":-10.045595,"median":-7.569398,"eighty":-5.438642,"marketCap":507132672},{"date":"2021-12-17","current":-4.096728,"twenty":-10.015817,"median":-7.544227,"eighty":-5.408069,"marketCap":512246615},{"date":"2021-12-23","current":-4.042195,"twenty":-9.975976,"median":-7.521387,"eighty":-5.387651,"marketCap":505428025},{"date":"2021-12-31","current":-4.045604,"twenty":-9.971847,"median":-7.498211,"eighty":-5.361107,"marketCap":505854187},{"date":"2022-01-07","current":-1.332629,"twenty":-9.964259,"median":-7.467915,"eighty":-5.350218,"marketCap":166629306},{"date":"2022-01-14","current":-1.158808,"twenty":-9.926629,"median":-7.424647,"eighty":-5.339443,"marketCap":144895049},{"date":"2022-01-21","current":-1.032703,"twenty":-9.844659,"median":-7.412401,"eighty":-5.325716,"marketCap":129127058},{"date":"2022-01-28","current":-0.94068,"twenty":-9.830987,"median":-7.361239,"eighty":-5.28488,"marketCap":117620687},{"date":"2022-02-04","current":-1.042927,"twenty":-9.828142,"median":-7.239071,"eighty":-5.274671,"marketCap":130405544},{"date":"2022-02-11","current":-0.879331,"twenty":-9.828142,"median":-7.11404,"eighty":-5.210014,"marketCap":109949772},{"date":"2022-02-18","current":-0.824799,"twenty":-9.815246,"median":-6.982936,"eighty":-5.158968,"marketCap":103131182},{"date":"2022-02-25","current":-0.84184,"twenty":-9.77584,"median":-6.945214,"eighty":-5.121535,"marketCap":105261991},{"date":"2022-03-04","current":-0.780491,"twenty":-9.676607,"median":-6.729525,"eighty":-5.035779,"marketCap":97591077},{"date":"2022-03-11","current":-0.861654,"twenty":-9.638097,"median":-6.681484,"eighty":-4.704402,"marketCap":110577807},{"date":"2022-03-18","current":-0.948152,"twenty":-9.620842,"median":-6.4826,"eighty":-4.424602,"marketCap":121678281},{"date":"2022-03-25","current":-0.758522,"twenty":-9.610201,"median":-6.061414,"eighty":-4.203747,"marketCap":97342625},{"date":"2022-04-01","current":-0.662043,"twenty":-9.605846,"median":-6.022958,"eighty":-4.104907,"marketCap":84961326},{"date":"2022-04-08","current":-0.598833,"twenty":-9.599856,"median":-5.889277,"eighty":-4.045604,"marketCap":76849441},{"date":"2022-04-14","current":-0.515662,"twenty":-9.58763,"median":-5.831531,"eighty":-4.027881,"marketCap":66175907},{"date":"2022-04-22","current":-0.465759,"twenty":-9.575497,"median":-5.808944,"eighty":-3.944038,"marketCap":59771787},{"date":"2022-04-29","current":-0.392578,"twenty":-9.557301,"median":-5.757899,"eighty":-1.479866,"marketCap":50380330},{"date":"2022-05-06","current":-0.325839,"twenty":-9.53989,"median":-5.741212,"eighty":-1.226292,"marketCap":44403002},{"date":"2022-05-13","current":-0.366568,"twenty":-9.529984,"median":-5.712242,"eighty":-1.083145,"marketCap":49953378},{"date":"2022-05-20","current":-0.338371,"twenty":-9.525305,"median":-5.693334,"eighty":-1.038156,"marketCap":46110810},{"date":"2022-05-27","current":-0.391633,"twenty":-9.520164,"median":-5.676853,"eighty":-0.997938,"marketCap":53368993},{"date":"2022-06-03","current":-0.410431,"twenty":-9.515666,"median":-5.655808,"eighty":-0.970672,"marketCap":55930705},{"date":"2022-06-10","current":-0.435496,"twenty":-9.505344,"median":-5.634624,"eighty":-0.943669,"marketCap":59346321},{"date":"2022-06-17","current":-0.34777,"twenty":-9.477136,"median":-5.574136,"eighty":-0.923638,"marketCap":47391666},{"date":"2022-06-24","current":-0.410431,"twenty":-9.43419,"median":-5.563316,"eighty":-0.888874,"marketCap":55930705},{"date":"2022-07-01","current":-0.391633,"twenty":-9.359655,"median":-5.545238,"eighty":-0.863653,"marketCap":53368993},{"date":"2022-07-08","current":-0.448028,"twenty":-9.352232,"median":-5.530126,"eighty":-0.848657,"marketCap":61054128},{"date":"2022-07-15","current":-0.491891,"twenty":-9.254145,"median":-5.523091,"eighty":-0.835023,"marketCap":67031456},{"date":"2022-07-22","current":-0.448028,"twenty":-9.211029,"median":-5.512462,"eighty":-0.815078,"marketCap":61054128},{"date":"2022-07-29","current":-0.3885,"twenty":-9.191326,"median":-5.508379,"eighty":-0.785137,"marketCap":52942041},{"date":"2022-08-05","current":-0.508107,"twenty":-9.155204,"median":-5.4967,"eighty":-0.753225,"marketCap":64214008},{"date":"2022-08-12","current":-0.484395,"twenty":-9.148637,"median":-5.479079,"eighty":-0.701965,"marketCap":61217354},{"date":"2022-08-19","current":-0.467458,"twenty":-9.147234,"median":-5.445605,"eighty":-0.662043,"marketCap":59076887},{"date":"2022-08-26","current":-0.443746,"twenty":-9.13439,"median":-5.421001,"eighty":-0.555584,"marketCap":56080234},{"date":"2022-09-02","current":-0.41326,"twenty":-9.123725,"median":-5.40909,"eighty":-0.508107,"marketCap":52227393},{"date":"2022-09-09","current":-0.447134,"twenty":-9.095737,"median":-5.39112,"eighty":-0.50129,"marketCap":56508327},{"date":"2022-09-16","current":-0.396323,"twenty":-9.080661,"median":-5.380164,"eighty":-0.491891,"marketCap":50086926},{"date":"2022-09-23","current":-0.359062,"twenty":-9.047229,"median":-5.363149,"eighty":-0.485701,"marketCap":45377899},{"date":"2022-09-30","current":-0.372612,"twenty":-9.036564,"median":-5.356343,"eighty":-0.481865,"marketCap":47090272},{"date":"2022-10-07","current":-0.365837,"twenty":-8.988063,"median":-5.349537,"eighty":-0.470845,"marketCap":46234086},{"date":"2022-10-14","current":-0.372612,"twenty":-8.91707,"median":-5.339904,"eighty":-0.467458,"marketCap":47090272},{"date":"2022-10-21","current":-0.352287,"twenty":-8.896367,"median":-5.334382,"eighty":-0.463441,"marketCap":44521712},{"date":"2022-10-28","current":-0.355675,"twenty":-8.866707,"median":-5.308701,"eighty":-0.453231,"marketCap":44949805},{"date":"2022-11-04","current":-0.378886,"twenty":-8.849155,"median":-5.293387,"eighty":-0.448028,"marketCap":42387437},{"date":"2022-11-11","current":-0.41333,"twenty":-8.846528,"median":-5.278074,"eighty":-0.443349,"marketCap":46240840},{"date":"2022-11-18","current":-0.384626,"twenty":-8.833393,"median":-5.255954,"eighty":-0.440013,"marketCap":43029670},{"date":"2022-11-25","current":-0.378847,"twenty":-8.810406,"median":-5.224241,"eighty":-0.432363,"marketCap":42383155},{"date":"2022-12-02","current":-0.367404,"twenty":-8.755896,"median":-5.206611,"eighty":-0.426867,"marketCap":41102969},{"date":"2022-12-09","current":-0.357913,"twenty":-8.700728,"median":-5.168057,"eighty":-0.418189,"marketCap":40041142},{"date":"2022-12-16","current":-0.341762,"twenty":-8.674724,"median":-5.13855,"eighty":-0.414946,"marketCap":38234324},{"date":"2022-12-23","current":-0.348115,"twenty":-8.650472,"median":-5.097714,"eighty":-0.41326,"marketCap":38945063},{"date":"2022-12-30","current":-0.364687,"twenty":-8.622226,"median":-5.068789,"eighty":-0.410431,"marketCap":40798978},{"date":"2023-01-06","current":-0.501354,"twenty":-8.598008,"median":-4.946281,"eighty":-0.409985,"marketCap":56088426},{"date":"2023-01-13","current":-0.627649,"twenty":-8.575473,"median":-4.713174,"eighty":-0.410431,"marketCap":70217572},{"date":"2023-01-20","current":-0.788388,"twenty":-8.50173,"median":-4.611083,"eighty":-0.410431,"marketCap":88200121},{"date":"2023-01-27","current":-0.723327,"twenty":-8.491879,"median":-4.39495,"eighty":-0.410431,"marketCap":80921470},{"date":"2023-02-03","current":-0.669747,"twenty":-8.329143,"median":-4.243283,"eighty":-0.410431,"marketCap":74927287},{"date":"2023-02-10","current":-0.581723,"twenty":-8.262014,"median":-4.163189,"eighty":-0.41326,"marketCap":65079701},{"date":"2023-02-17","current":-0.650611,"twenty":-8.242425,"median":-4.106952,"eighty":-0.41326,"marketCap":72786508},{"date":"2023-02-24","current":-0.597032,"twenty":-8.234453,"median":-4.079686,"eighty":-0.41326,"marketCap":66792325},{"date":"2023-03-03","current":-0.577896,"twenty":-8.221951,"median":-4.045604,"eighty":-0.413316,"marketCap":64651545},{"date":"2023-03-10","current":-0.590143,"twenty":-8.191554,"median":-4.031971,"eighty":-0.413517,"marketCap":56680917},{"date":"2023-03-17","current":-0.590143,"twenty":-8.167722,"median":-4.008113,"eighty":-0.415406,"marketCap":56680917},{"date":"2023-03-24","current":-0.505199,"twenty":-8.163326,"median":-3.939948,"eighty":-0.416531,"marketCap":48522300},{"date":"2023-03-31","current":-0.390746,"twenty":-8.111918,"median":-2.590277,"eighty":-0.416531,"marketCap":37529637},{"date":"2023-04-06","current":-0.4055,"twenty":-8.055883,"median":-1.353079,"eighty":-0.413424,"marketCap":38946660},{"date":"2023-04-14","current":-0.431028,"twenty":-7.991091,"median":-1.307067,"eighty":-0.41326,"marketCap":41398539},{"date":"2023-04-21","current":-0.491786,"twenty":-7.962978,"median":-1.158808,"eighty":-0.41326,"marketCap":47234097},{"date":"2023-04-28","current":-0.478374,"twenty":-7.929243,"median":-1.114501,"eighty":-0.413316,"marketCap":45945895},{"date":"2023-05-05","current":-0.608027,"twenty":-7.879321,"median":-1.07701,"eighty":-0.41347,"marketCap":58398521},{"date":"2023-05-12","current":-0.57675,"twenty":-7.842547,"median":-1.041223,"eighty":-0.414868,"marketCap":48092899},{"date":"2023-05-19","current":-0.571601,"twenty":-7.830437,"median":-1.032703,"eighty":-0.415815,"marketCap":47663498},{"date":"2023-05-26","current":-0.566451,"twenty":-7.809965,"median":-0.996915,"eighty":-0.416365,"marketCap":47234097},{"date":"2023-06-02","current":-0.612797,"twenty":-7.78311,"median":-0.983283,"eighty":-0.416697,"marketCap":51098705},{"date":"2023-06-09","current":-0.573871,"twenty":-7.747984,"median":-0.964787,"eighty":-0.416697,"marketCap":47852840},{"date":"2023-06-16","current":-0.573871,"twenty":-7.729125,"median":-0.944416,"eighty":-0.417691,"marketCap":47852840},{"date":"2023-06-23","current":-0.506728,"twenty":-7.709921,"median":-0.932731,"eighty":-0.419312,"marketCap":42254057},{"date":"2023-06-30","current":-0.485808,"twenty":-7.64464,"median":-0.923638,"eighty":-0.41983,"marketCap":40509604},{"date":"2023-07-07","current":-0.516484,"twenty":-7.634149,"median":-0.907332,"eighty":-0.422337,"marketCap":43067556},{"date":"2023-07-14","current":-0.500885,"twenty":-7.62586,"median":-0.879331,"eighty":-0.42333,"marketCap":41766828},{"date":"2023-07-21","current":-0.521701,"twenty":-7.620404,"median":-0.865698,"eighty":-0.424643,"marketCap":43502582},{"date":"2023-07-28","current":-0.456489,"twenty":-7.611315,"median":-0.858327,"eighty":-0.428321,"marketCap":38064759},{"date":"2023-08-04","current":-0.464262,"twenty":-7.597056,"median":-0.843544,"eighty":-0.429172,"marketCap":38712947},{"date":"2023-08-11","current":-0.513021,"twenty":-7.585562,"median":-0.835023,"eighty":-0.429219,"marketCap":42197504},{"date":"2023-08-18","current":-0.475999,"twenty":-7.575851,"median":-0.824799,"eighty":-0.430668,"marketCap":39152323},{"date":"2023-08-25","current":-0.459815,"twenty":-7.57395,"median":-0.815078,"eighty":-0.432096,"marketCap":37821144},{"date":"2023-09-01","current":-0.455372,"twenty":-7.57395,"median":-0.809345,"eighty":-0.432363,"marketCap":37455723},{"date":"2023-09-08","current":-0.454843,"twenty":-7.57395,"median":-0.786763,"eighty":-0.434243,"marketCap":37412220},{"date":"2023-09-15","current":-0.425754,"twenty":-7.571219,"median":-0.784561,"eighty":-0.431829,"marketCap":35019578},{"date":"2023-09-22","current":-0.420466,"twenty":-7.559388,"median":-0.774994,"eighty":-0.4278,"marketCap":34584552},{"date":"2023-09-29","current":-0.386088,"twenty":-7.547965,"median":-0.753225,"eighty":-0.42311,"marketCap":31756884},{"date":"2023-10-06","current":-0.412532,"twenty":-7.544112,"median":-0.736722,"eighty":-0.423089,"marketCap":33932013},{"date":"2023-10-13","current":-0.402589,"twenty":-7.543654,"median":-0.723327,"eighty":-0.420212,"marketCap":33114165},{"date":"2023-10-20","current":-0.396666,"twenty":-7.516934,"median":-0.715473,"eighty":-0.417371,"marketCap":32626936},{"date":"2023-10-27","current":-0.583035,"twenty":-7.49912,"median":-0.71361,"eighty":-0.416697,"marketCap":47956382},{"date":"2023-11-03","current":-0.683244,"twenty":-7.499115,"median":-0.710283,"eighty":-0.417821,"marketCap":56198886},{"date":"2023-11-10","current":-0.706445,"twenty":-7.498211,"median":-0.704205,"eighty":-0.419183,"marketCap":57697522},{"date":"2023-11-17","current":-0.570661,"twenty":-7.478031,"median":-0.697271,"eighty":-0.419249,"marketCap":46607609},{"date":"2023-11-24","current":-0.656903,"twenty":-7.473977,"median":-0.691985,"eighty":-0.419714,"marketCap":53651203},{"date":"2023-12-01","current":-0.642223,"twenty":-7.464885,"median":-0.683244,"eighty":-0.420339,"marketCap":52452293},{"date":"2023-12-08","current":-0.59635,"twenty":-7.454787,"median":-0.675351,"eighty":-0.420677,"marketCap":48705701},{"date":"2023-12-15","current":-0.534054,"twenty":-7.430271,"median":-0.67166,"eighty":-0.422517,"marketCap":43617828},{"date":"2023-12-21","current":-0.559652,"twenty":-7.424647,"median":-0.665743,"eighty":-0.42302,"marketCap":45708427},{"date":"2023-12-29","current":-0.602864,"twenty":-7.422198,"median":-0.662043,"eighty":-0.423068,"marketCap":49237717},{"date":"2024-01-05","current":-0.678004,"twenty":-7.41485,"median":-0.665743,"eighty":-0.423099,"marketCap":55374635},{"date":"2024-01-12","current":-0.669747,"twenty":-7.39622,"median":-0.669442,"eighty":-0.42311,"marketCap":54700249},{"date":"2024-01-19","current":-0.633049,"twenty":-7.389986,"median":-0.664609,"eighty":-0.42311,"marketCap":51702975},{"date":"2024-01-26","current":-0.642223,"twenty":-7.355782,"median":-0.657728,"eighty":-0.42311,"marketCap":52452293},{"date":"2024-02-02","current":-0.660568,"twenty":-7.321557,"median":-0.660568,"eighty":-0.42311,"marketCap":53950578},{"date":"2024-02-09","current":-0.648123,"twenty":-7.26876,"median":-0.660568,"eighty":-0.423297,"marketCap":52934118},{"date":"2024-02-16","current":-0.614616,"twenty":-7.236963,"median":-0.659611,"eighty":-0.424338,"marketCap":50197494},{"date":"2024-02-23","current":-0.765876,"twenty":-7.194793,"median":-0.658554,"eighty":-0.42527,"marketCap":62551395},{"date":"2024-03-01","current":-0.947772,"twenty":-7.117962,"median":-0.660568,"eighty":-0.427118,"marketCap":77407351},{"date":"2024-03-08","current":-0.890331,"twenty":-7.090439,"median":-0.660568,"eighty":-0.429168,"marketCap":72715996},{"date":"2024-03-15","current":-0.750566,"twenty":-7.043844,"median":-0.661306,"eighty":-0.429196,"marketCap":65808912},{"date":"2024-03-22","current":-0.819867,"twenty":-6.973101,"median":-0.664609,"eighty":-0.429949,"marketCap":71885094},{"date":"2024-03-28","current":-0.844894,"twenty":-6.955722,"median":-0.669747,"eighty":-0.431295,"marketCap":74079482},{"date":"2024-04-05","current":-0.839285,"twenty":-6.909104,"median":-0.674413,"eighty":-0.432363,"marketCap":73587636},{"date":"2024-04-12","current":-0.914799,"twenty":-6.761152,"median":-0.676261,"eighty":-0.43299,"marketCap":80208632},{"date":"2024-04-19","current":-0.684459,"twenty":-6.740067,"median":-0.678004,"eighty":-0.436123,"marketCap":60012704},{"date":"2024-04-26","current":-0.705948,"twenty":-6.708364,"median":-0.678922,"eighty":-0.438975,"marketCap":61896850},{"date":"2024-05-03","current":-0.75367,"twenty":-6.6915,"median":-0.678922,"eighty":-0.440359,"marketCap":66080998},{"date":"2024-05-10","current":-0.609039,"twenty":-6.678202,"median":-0.678922,"eighty":-0.440611,"marketCap":60652358},{"date":"2024-05-17","current":-0.513742,"twenty":-6.630046,"median":-0.677546,"eighty":-0.441649,"marketCap":51162002},{"date":"2024-05-24","current":-0.470603,"twenty":-6.486995,"median":-0.675351,"eighty":-0.441762,"marketCap":46865956},{"date":"2024-05-31","current":-0.46276,"twenty":-6.475275,"median":-0.67488,"eighty":-0.441762,"marketCap":46084841},{"date":"2024-06-07","current":-0.423621,"twenty":-6.174951,"median":-0.669747,"eighty":-0.441762,"marketCap":42187156},{"date":"2024-06-14","current":-0.392169,"twenty":-6.061414,"median":-0.664609,"eighty":-0.440359,"marketCap":39054950},{"date":"2024-06-21","current":-0.353737,"twenty":-6.035651,"median":-0.662043,"eighty":-0.432363,"marketCap":35227564},{"date":"2024-06-28","current":-0.274518,"twenty":-6.025673,"median":-0.660568,"eighty":-0.429172,"marketCap":27338465},{"date":"2024-07-05","current":-0.316951,"twenty":-6.022592,"median":-0.660568,"eighty":-0.424417,"marketCap":31564210},{"date":"2024-07-12","current":-0.407777,"twenty":-5.987123,"median":-0.659611,"eighty":-0.42311,"marketCap":40609337},{"date":"2024-07-19","current":-0.395071,"twenty":-5.919348,"median":-0.656903,"eighty":-0.423089,"marketCap":39343956},{"date":"2024-07-26","current":-0.423464,"twenty":-5.875079,"median":-0.654439,"eighty":-0.423089,"marketCap":42171535},{"date":"2024-08-02","current":-0.380404,"twenty":-5.845164,"median":-0.651196,"eighty":-0.420624,"marketCap":37883301},{"date":"2024-08-09","current":-0.580265,"twenty":-5.820031,"median":-0.650611,"eighty":-0.420624,"marketCap":43946402},{"date":"2024-08-16","current":-0.553995,"twenty":-5.812354,"median":-0.647693,"eighty":-0.421947,"marketCap":41956829},{"date":"2024-08-23","current":-0.583642,"twenty":-5.808263,"median":-0.642957,"eighty":-0.422882,"marketCap":44202090},{"date":"2024-08-30","current":-0.53511,"twenty":-5.803499,"median":-0.642223,"eighty":-0.42302,"marketCap":40526573},{"date":"2024-09-06","current":-0.527936,"twenty":-5.784442,"median":-0.641626,"eighty":-0.423078,"marketCap":39983236},{"date":"2024-09-13","current":-0.624577,"twenty":-5.756245,"median":-0.638545,"eighty":-0.42311,"marketCap":47302309},{"date":"2024-09-20","current":-0.385718,"twenty":-5.749426,"median":-0.634634,"eighty":-0.42311,"marketCap":29212372},{"date":"2024-09-27","current":-0.339297,"twenty":-5.741553,"median":-0.633395,"eighty":-0.421541,"marketCap":25696660},{"date":"2024-10-04","current":-0.344361,"twenty":-5.739351,"median":-0.633166,"eighty":-0.419209,"marketCap":26080192},{"date":"2024-10-11","current":-0.321573,"twenty":-5.728366,"median":-0.633049,"eighty":-0.416697,"marketCap":24354297},{"date":"2024-10-18","current":-0.305958,"twenty":-5.706876,"median":-0.628514,"eighty":-0.415699,"marketCap":23171739},{"date":"2024-10-25","current":-0.354489,"twenty":-5.697363,"median":-0.627649,"eighty":-0.41326,"marketCap":26847256},{"date":"2024-11-01","current":-0.403021,"twenty":-5.6937,"median":-0.624745,"eighty":-0.412456,"marketCap":30522774},{"date":"2024-11-08","current":-0.491482,"twenty":-5.690038,"median":-0.623874,"eighty":-0.412456,"marketCap":37821051},{"date":"2024-11-15","current":-0.924604,"twenty":-5.683445,"median":-0.624745,"eighty":-0.41261,"marketCap":71151084},{"date":"2024-11-22","current":-0.966566,"twenty":-5.673923,"median":-0.627649,"eighty":-0.41294,"marketCap":74380163},{"date":"2024-11-29","current":-1.230394,"twenty":-5.666784,"median":-0.627649,"eighty":-0.41326,"marketCap":94682533},{"date":"2024-12-06","current":-1.382807,"twenty":-5.653766,"median":-0.632262,"eighty":-0.41326,"marketCap":106411141},{"date":"2024-12-13","current":-1.643259,"twenty":-5.643931,"median":-0.633049,"eighty":-0.413274,"marketCap":126453700},{"date":"2024-12-20","current":-1.921557,"twenty":-5.636206,"median":-0.633395,"eighty":-0.413377,"marketCap":147869546},{"date":"2024-12-27","current":-1.98474,"twenty":-5.631987,"median":-0.633966,"eighty":-0.413564,"marketCap":152731722},{"date":"2025-01-03","current":-2.094227,"twenty":-5.630753,"median":-0.636448,"eighty":-0.414582,"marketCap":161157020},{"date":"2025-01-10","current":-1.625895,"twenty":-5.596659,"median":-0.639787,"eighty":-0.415354,"marketCap":125117530},{"date":"2025-01-17","current":-1.651458,"twenty":-5.574136,"median":-0.642223,"eighty":-0.415699,"marketCap":127084670},{"date":"2025-01-24","current":-1.467695,"twenty":-5.569808,"median":-0.642223,"eighty":-0.415715,"marketCap":112943531},{"date":"2025-01-31","current":-1.244382,"twenty":-5.560174,"median":-0.645247,"eighty":-0.41579,"marketCap":95758893},{"date":"2025-02-07","current":-1.327823,"twenty":-5.551372,"median":-0.649563,"eighty":-0.416199,"marketCap":102179935},{"date":"2025-02-14","current":-1.141648,"twenty":-5.545238,"median":-0.650921,"eighty":-0.416697,"marketCap":87853216},{"date":"2025-02-21","current":-0.898559,"twenty":-5.542261,"median":-0.651398,"eighty":-0.416697,"marketCap":69146828},{"date":"2025-02-28","current":-0.813671,"twenty":-5.530263,"median":-0.655389,"eighty":-0.416922,"marketCap":62614438},{"date":"2025-03-07","current":-0.62412,"twenty":-5.529897,"median":-0.656146,"eighty":-0.418093,"marketCap":48027909},{"date":"2025-03-14","current":-0.533093,"twenty":-5.528536,"median":-0.651398,"eighty":-0.419196,"marketCap":69947717},{"date":"2025-03-21","current":-0.50094,"twenty":-5.52241,"median":-0.650921,"eighty":-0.419365,"marketCap":65728843},{"date":"2025-03-28","current":-0.424984,"twenty":-5.518327,"median":-0.650165,"eighty":-0.419957,"marketCap":55762516},{"date":"2025-04-04","current":-0.277264,"twenty":-5.512714,"median":-0.647693,"eighty":-0.416922,"marketCap":36380150},{"date":"2025-04-11","current":-0.190124,"twenty":-5.511529,"median":-0.642957,"eighty":-0.415764,"marketCap":24946388},{"date":"2025-04-17","current":-0.218084,"twenty":-5.509479,"median":-0.642223,"eighty":-0.414837,"marketCap":28614975},{"date":"2025-04-25","current":-0.253965,"twenty":-5.508379,"median":-0.641626,"eighty":-0.41326,"marketCap":33322994},{"date":"2025-05-02","current":-0.260955,"twenty":-5.506076,"median":-0.637592,"eighty":-0.412405,"marketCap":34240141},{"date":"2025-05-09","current":-0.514351,"twenty":-5.504339,"median":-0.633966,"eighty":-0.412405,"marketCap":27394308},{"date":"2025-05-16","current":-0.670493,"twenty":-5.489061,"median":-0.637592,"eighty":-0.412532,"marketCap":35710437},{"date":"2025-05-23","current":-0.650975,"twenty":-5.482255,"median":-0.639787,"eighty":-0.412727,"marketCap":34670921},{"date":"2025-05-30","current":-0.658438,"twenty":-5.479714,"median":-0.64141,"eighty":-0.413153,"marketCap":35068383},{"date":"2025-06-06","current":-0.694603,"twenty":-5.458388,"median":-0.64179,"eighty":-0.41326,"marketCap":36994546},{"date":"2025-06-13","current":-0.921927,"twenty":-5.451945,"median":-0.642223,"eighty":-0.41326,"marketCap":49101852},{"date":"2025-06-20","current":-0.960963,"twenty":-5.4444,"median":-0.64259,"eighty":-0.413302,"marketCap":51180884},{"date":"2025-06-27","current":-0.819746,"twenty":-5.438642,"median":-0.646382,"eighty":-0.41347,"marketCap":43659679},{"date":"2025-07-03","current":-0.900113,"twenty":-5.43121,"median":-0.648123,"eighty":-0.414073,"marketCap":47940039},{"date":"2025-07-11","current":-1.009183,"twenty":-5.41964,"median":-0.650388,"eighty":-0.415182,"marketCap":53749100},{"date":"2025-07-18","current":-1.037886,"twenty":-5.416237,"median":-0.650975,"eighty":-0.415699,"marketCap":55277801},{"date":"2025-07-25","current":-1.02296,"twenty":-5.410111,"median":-0.651196,"eighty":-0.415715,"marketCap":54482876},{"date":"2025-08-01","current":-0.83582,"twenty":-5.399137,"median":-0.652123,"eighty":-0.41579,"marketCap":44515751},{"date":"2025-08-08","current":-0.674144,"twenty":-5.391269,"median":-0.656146,"eighty":-0.416199,"marketCap":50010670},{"date":"2025-08-15","current":-0.628952,"twenty":-5.389012,"median":-0.652123,"eighty":-0.416697,"marketCap":46658171},{"date":"2025-08-22","current":-0.815938,"twenty":-5.384248,"median":-0.654914,"eighty":-0.416697,"marketCap":60529520},{"date":"2025-08-29","current":-0.917101,"twenty":-5.377245,"median":-0.656903,"eighty":-0.417147,"marketCap":68034196},{"date":"2025-09-05","current":-0.890566,"twenty":-5.371604,"median":-0.658554,"eighty":-0.418093,"marketCap":66065756},{"date":"2025-09-12","current":-0.902175,"twenty":-5.365191,"median":-0.660568,"eighty":-0.419196,"marketCap":66926949},{"date":"2025-09-19","current":-0.828376,"twenty":-5.359746,"median":-0.660568,"eighty":-0.419365,"marketCap":61452226},{"date":"2025-09-26","current":-0.776136,"twenty":-5.359065,"median":-0.661306,"eighty":-0.419957,"marketCap":57576860},{"date":"2025-10-03","current":-0.849106,"twenty":-5.355662,"median":-0.664609,"eighty":-0.420519,"marketCap":62990069},{"date":"2025-10-10","current":-0.846618,"twenty":-5.352259,"median":-0.667671,"eighty":-0.421136,"marketCap":62805528},{"date":"2025-10-17","current":-0.871494,"twenty":-5.343757,"median":-0.669594,"eighty":-0.421947,"marketCap":64650940},{"date":"2025-10-24","current":-0.786915,"twenty":-5.315507,"median":-0.669594,"eighty":-0.421947,"marketCap":58376539},{"date":"2025-10-31","current":-0.679948,"twenty":-5.278074,"median":-0.669594,"eighty":-0.421947,"marketCap":50441266},{"date":"2025-11-07","current":-0.505132,"twenty":-5.223683,"median":-0.66369,"eighty":-0.421947,"marketCap":43674755},{"date":"2025-11-14","current":-0.432008,"twenty":-5.166239,"median":-0.660568,"eighty":-0.421947,"marketCap":37352242},{"date":"2025-11-21","current":-0.587872,"twenty":-5.095672,"median":-0.658496,"eighty":-0.421947,"marketCap":50828587},{"date":"2025-11-28","current":-0.681818,"twenty":-4.939815,"median":-0.657671,"eighty":-0.421947,"marketCap":58951315},{"date":"2025-12-05","current":-0.718115,"twenty":-4.585696,"median":-0.656903,"eighty":-0.421947,"marketCap":62089642},{"date":"2025-12-12","current":-0.819178,"twenty":-4.224878,"median":-0.656903,"eighty":-0.421947,"marketCap":70827728},{"date":"2025-12-19","current":-0.738043,"twenty":-4.100818,"median":-0.656903,"eighty":-0.421947,"marketCap":63812645},{"date":"2025-12-26","current":-0.748718,"twenty":-4.045604,"median":-0.656903,"eighty":-0.421947,"marketCap":64735682},{"date":"2026-01-02","current":-0.663313,"twenty":-4.015611,"median":-0.656193,"eighty":-0.421947,"marketCap":57351384},{"date":"2026-01-09","current":-0.735196,"twenty":-3.734771,"median":-0.654914,"eighty":-0.421947,"marketCap":63566502},{"date":"2026-01-16","current":-0.587872,"twenty":-1.978084,"median":-0.651196,"eighty":-0.421947,"marketCap":50828587},{"date":"2026-01-23","current":-0.6078,"twenty":-1.920978,"median":-0.650729,"eighty":-0.421947,"marketCap":52551590},{"date":"2026-01-30","current":-0.577552,"twenty":-1.739144,"median":-0.648601,"eighty":-0.421947,"marketCap":49936317},{"date":"2026-02-05","current":-0.503179,"twenty":-1.646539,"median":-0.643665,"eighty":-0.421947,"marketCap":43505824}],"updateTime":1770413619289},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALGS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609316350","title":"Aligos Therapeutics Appoints New Principal Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609316350","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609316350?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:37","pubTimestamp":1770241059,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics ( ($ALGS) ) has provided an update. On January 29, 2026, Aligos Therapeutics, Inc. appointed Nikhil Aneja as its Principal Acco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aligos-therapeutics-appoints-new-principal-accounting-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aligos-therapeutics-appoints-new-principal-accounting-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4566","BK4162","PFG","LU1989772923.USD","BK4139","ALGS","LU1989772840.SGD","BK4588","BK4585","BK4534"],"gpt_icon":0},{"id":"2609318025","title":"Aligos Therapeutics ernennt Nikhil Aneja zum Principal Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609318025","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609318025?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:10","pubTimestamp":1770239409,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics Inc. hat bekannt gegeben, dass Nikhil Aneja ab sofort als Principal Accounting Officer des Unternehmens ernannt wurde. Er folgt auf Lesley Ann Calhoun, die weiterhin als Executive Vice President, Chief Operating Officer und Chief Financial Officer ttig ist.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDLW1Gzs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4139","BK4505"],"gpt_icon":0},{"id":"2607045682","title":"Aligos Therapeutics announces inducement grants under Nasdaq listing rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045682?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:20","pubTimestamp":1769779229,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to pur...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-thefly-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-thefly-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALGS","NQmain","BK4505"],"gpt_icon":0},{"id":"2607666043","title":"Aligos Therapeutics Grants Stock Options to New Employees Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2607666043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607666043?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:00","pubTimestamp":1769778009,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics Inc. has granted non-qualified stock options to purchase a total of 81,100 shares to newly hired employees, effective January 29, 2026. The options were issued under the company's 2024 Inducement Plan. Each grant has an exercise price set at the closing price of Aligos' common stock on the grant date. Vesting will occur over four years, with 25% of the shares vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 30, 2026, and is solely responsible for the informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL2PkgJX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","ALGS","IE00B64PRP62.GBP","SG9999014013.SGD","BK4139","SG9999014021.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4112","IE00BGHQF748.EUR","BK4505","SG9999014005.SGD","BK4588","IE00BKPKM429.USD","NDAQ"],"gpt_icon":0},{"id":"2607045826","title":"Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045826","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045826?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:00","pubTimestamp":1769778000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Jan.  30, 2026  (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/30/3229483/0/en/Aligos-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","ALGS"],"gpt_icon":0},{"id":"2605867214","title":"BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605867214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605867214?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:49","pubTimestamp":1769010597,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers CompaniesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL6N3YM11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HL","NEM","LXRX","SLB","LBRT","AMBQ","LSTA","LUCD","BK4533","CDE","HAL","UAL","OCGN","ROCK","LU0985481810.HKD","OCUL","TRV","CBIO","CNX","ALB","SCHW","LU2430703095.HKD","BKR","IE00BBT3K403.USD","BK4141","GM","IE00B775SV38.USD","JNJ","NATH","DXC","INTC","TFC","BK4534","LPTH","BIOA","LNG","LU0154245673.USD","F","WMB","NNE","ALGS","AVR","TDY","IE00B29SXL02.USD","PLD","EXE","KHC"],"gpt_icon":1},{"id":"2605485995","title":"BUZZ-Aligos rises as mid‑stage trial for hepatitis B drug advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2605485995","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605485995?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:00","pubTimestamp":1769007631,"startTime":"0","endTime":"0","summary":"BUZZ-Aligos rises as midstage trial for hepatitis B drug advances** Shares of biotech firm Aligos Therapeutics ALGS.O up 3% at $8.25** Co says it is testing its experimental hepatitis B drug, pevifoscorvir sodium, aimed at blocking virus replication, in a mid-stage study with 144 patients** Expects first interim data from study in early 2026, main results in 2027** ALGS says earlier tests showed the oral drug reduced infection markers** Separately, co announced that its chief medical officer, Dr Hardean Achneck, has resigned and a search for a successor is underway** ALGS was down ~25% in 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL4N3YM1HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4139","BK4505"],"gpt_icon":0},{"id":"2605107109","title":"Aligos Therapeutics provides update for Phase 2 study of pevifoscorvir sodium","url":"https://stock-news.laohu8.com/highlight/detail?id=2605107109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605107109?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:10","pubTimestamp":1769001022,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics (ALGS) announced a progress update for the Phase 2 B-SUPREME study of pevifoscorvir sodium in subjects with chronic hepatitis B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-provides-update-for-phase-2-study-of-pevifoscorvir-sodium-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-provides-update-for-phase-2-study-of-pevifoscorvir-sodium-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALGS","BK4505","BK4139"],"gpt_icon":0},{"id":"2605102299","title":"Aligos Therapeutics Chief Medical Officer Hardean Achneck Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102299","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102299?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000420,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics Inc. announced that Hardean Achneck, MD has resigned from his position as Executive Vice President, Chief Medical Officer. The company has begun a formal search for his successor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL32FtZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4505","BK4139","LU2095319765.USD","LU0314104364.USD","BK4588","IE00BKPKM429.USD","SG9999014039.USD","NDAQ","BK4585","SG9999014005.SGD","LU2210150020.SGD","LU2210149790.SGD","SG9999014013.SGD","BK4112","SG9999014021.USD","ALGS","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2605102451","title":"Aligos Therapeutics Inc: Study Remains on Track to Complete Enrollment, With Topline Data Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102451?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nTUA9YRJTD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALGS","BK4505"],"gpt_icon":0},{"id":"2605981107","title":"Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2605981107","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605981107?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000400,"startTime":"0","endTime":"0","summary":"Interim analyses on track for the first and second half of 2026SOUTH SAN FRANCISCO, Calif., Jan.  21, 2026  (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/21/3222721/0/en/Aligos-Therapeutics-Provides-Phase-2-B-SUPREME-Study-Progress-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","BK4505","BK4097","ALGS","BK4139","PRGS"],"gpt_icon":0},{"id":"2605814659","title":"Aligos Therapeutics management to meet virtually with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2605814659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605814659?lang=en_us&edition=fundamental","pubTime":"2026-01-21 03:55","pubTimestamp":1768938925,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held on January 22 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-management-to-meet-virtually-with-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-management-to-meet-virtually-with-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALGS","BK4139","BK4505"],"gpt_icon":0},{"id":"2603984414","title":"Aligos’ New Phase 1 Hepatitis B Study Signals Steady Progress in High-Need Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2603984414","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603984414?lang=en_us&edition=fundamental","pubTime":"2026-01-16 00:35","pubTimestamp":1768494930,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics, Inc. ($ALGS) announced an update on their ongoing clinical study. Aligos Therapeutics Advances Phase 1 Study of Pevifoscorvir ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aligos-new-phase-1-hepatitis-b-study-signals-steady-progress-in-high-need-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aligos-new-phase-1-hepatitis-b-study-signals-steady-progress-in-high-need-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065732104.USD","BK4097","PRGS","ALGS","BK4139","BK4505"],"gpt_icon":0},{"id":"2603684789","title":"Aligos Therapeutics appoints James Hassard as EVP, CCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2603684789","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603684789?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:16","pubTimestamp":1768310177,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics (ALGS) announced the appointment of James Hassard, MBA as Executive Vice President, Chief Commercial Officer. Hassard will lead...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-appoints-james-hassard-as-evp-cco-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aligos-therapeutics-appoints-james-hassard-as-evp-cco-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALGS","BK4139","LU2294711713.HKD","LU2506951792.HKD","BK4505","LU0823414551.USD","LU0823414478.USD","BK4009","CCO","LU2249611893.SGD","LU2357125470.USD","EVP"],"gpt_icon":0},{"id":"2603684808","title":"Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603684808","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603684808?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:00","pubTimestamp":1768309200,"startTime":"0","endTime":"0","summary":"Seasoned leader with global commercialization and marketing expertiseSOUTH SAN FRANCISCO, Calif., Jan.  13, 2026  (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (“Aligos”, Nasdaq: ALGS), a clinical sta","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/13/3217728/0/en/Aligos-Therapeutics-Strengthens-Senior-Leadership-Team-with-the-Appointment-of-James-Hassard-as-Executive-Vice-President-Chief-Commercial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","TISI","BK4139","ALGS","BK4120"],"gpt_icon":0},{"id":"2601238653","title":"Aligos Therapeutics Initiated at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2601238653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601238653?lang=en_us&edition=fundamental","pubTime":"2026-01-08 04:22","pubTimestamp":1767817320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2026 15:22 ET (20:22 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","ALGS"],"gpt_icon":0},{"id":"2601015288","title":"UBS Initiates Aligos Therapeutics at Buy With $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2601015288","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601015288?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:35","pubTimestamp":1767796547,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics (ALGS) has an average rating of buy and mean price target of $68.20, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALGS"],"gpt_icon":0},{"id":"2590509684","title":"Aligos Therapeutics Grants Stock Options to New Hires Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2590509684","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590509684?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:00","pubTimestamp":1765544410,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics Inc. has granted non-qualified stock options to purchase a total of 14,100 shares to newly hired employees as part of its 2024 Inducement Plan. The options have an exercise price equal to the closing price of Aligos' common stock on the grant date. Vesting will occur over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL1DsdhL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","BK4588","SG9999014005.SGD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD","ALGS","LU2210150020.SGD","BK4139","BK4505","SG9999014013.SGD"],"gpt_icon":0},{"id":"2590600501","title":"Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2590600501","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590600501?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:00","pubTimestamp":1765544400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  12, 2025  (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/12/3204598/0/en/Aligos-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALGS","BK4505","BK4139"],"gpt_icon":0},{"id":"2590385516","title":"Aligos Therapeutics Reports Positive Phase 1 Results for Pevifoscorvir Sodium in Chronic Hepatitis B","url":"https://stock-news.laohu8.com/highlight/detail?id=2590385516","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590385516?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:01","pubTimestamp":1765458071,"startTime":"0","endTime":"0","summary":"Aligos Therapeutics Inc., a clinical-stage biopharmaceutical company focused on liver and viral diseases, has announced positive data from four presentations at the HEP-DART 2025 Meeting held from December 7 to 11, 2025, in Honolulu, Hawaii. The results, which have already been presented, include Phase 1 monotherapy data for pevifoscorvir sodium, a small molecule CAM-E under investigation for chronic hepatitis B virus  infection. Additionally, new nonclinical data for ALG-055009, a thyroid hormone receptor beta agonist in development for obesity and metabolic dysfunction-associated steatohepatitis , demonstrated synergistic effects in combination with incretin receptor agonists. Early-stage data from antisense oligonucleotide  programs targeting HBV and hepatitis delta virus  were also presented. The presentations are available on the Aligos Therapeutics website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL6DHNmM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","NDAQ","BK4139","SG9999014013.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD","BK4588","LU2210150020.SGD","BK4505","SG9999014021.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0314104364.USD","ALGS","LU2095319765.USD","BK4112"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}